Recurrent Severe Hypophosphatemia Following Intravenous Ferric Carboxymaltose Infusion: A Case Report. [PDF]
Enchill LA +4 more
europepmc +1 more source
Ferric Carboxymaltose Therapy Improves the Index of Cardiac Electrophysiological Balance in Iron-Deficient Heart Failure with Reduced Ejection Fraction. [PDF]
Tunca Ç +11 more
europepmc +1 more source
Prescribing and dosing patterns of ferric carboxymaltose for iron deficiency anemia: a real-world study from Saudi Arabia. [PDF]
Alzahrani YA +6 more
europepmc +1 more source
Perioperative Hypophosphatemia Following a Fixed High-Dose Ferric Carboxymaltose Protocol in Staged Bilateral Total Knee Arthroplasty: A Retrospective Cohort Study. [PDF]
Lee J, Jeong M, Kim DS.
europepmc +1 more source
Multidisciplinary approach to implementing ferric carboxymaltose for IV iron replacement in heart failure with iron deficiency. [PDF]
Fudim M +4 more
europepmc +1 more source
Calcitriol as a Therapeutic Strategy for Ferric Carboxymaltose-Induced Hypophosphatemia. [PDF]
Patel F, Modi P, Modi B, Modi R.
europepmc +1 more source
Administration of Intravenous Ferric Carboxymaltose in a Patient With Iron-Deficiency Anemia and Allergy to 2 Oral Iron Preparations. [PDF]
Wallace J, Trabal A.
europepmc +1 more source
Intravenous Ferric Carboxymaltose Versus Oral Ferrous Sulfate for Iron Deficiency Anemia: A Retrospective Cohort Study of Iron Store Repletion and Safety. [PDF]
El Ouafa Y +5 more
europepmc +1 more source
Effectiveness and Safety of Ferric Carboxymaltose in Iron Deficiency Anemia. [PDF]
Jain A.
europepmc +1 more source
Cost-effectiveness of using Intravenous Ferric Carboxymaltose compared to Intravenous Iron Sucrose for treatment of iron deficiency anemia in pregnancy. [PDF]
Joshi B +6 more
europepmc +1 more source

